Happify Launches the First Prescription Digital Therapeutics to Treat Both MDD and GAD
Similar Posts
YourCoach.Health Announces Partnership to Enhance Medisafe’s Comprehensive Global Digital Health Offerings with Health Coaches
New digital health partnership YourCoach.Health, an operating system for behavior change powered by health coaches, partnered with Medisafe, the…
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
TRUDHESA Is the First and Only Therapeutic to Use POD technology to Deliver Dihydroergotamine Mesylate (DHE) to the Vascular-Rich…
